OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Distinct sensitivities to SARS-CoV-2 variants in vaccinated humans and mice
Alexandra C. Walls, Laura A. VanBlargan, Kaichun Wu, et al.
Cell Reports (2022) Vol. 40, Iss. 9, pp. 111299-111299
Open Access | Times Cited: 13
Alexandra C. Walls, Laura A. VanBlargan, Kaichun Wu, et al.
Cell Reports (2022) Vol. 40, Iss. 9, pp. 111299-111299
Open Access | Times Cited: 13
Showing 13 citing articles:
Mosaic RBD nanoparticles protect against challenge by diverse sarbecoviruses in animal models
Alexander A. Cohen, Neeltje van Doremalen, Allison J. Greaney, et al.
Science (2022) Vol. 377, Iss. 6606
Open Access | Times Cited: 188
Alexander A. Cohen, Neeltje van Doremalen, Allison J. Greaney, et al.
Science (2022) Vol. 377, Iss. 6606
Open Access | Times Cited: 188
Nanotechnology’s frontier in combatting infectious and inflammatory diseases: prevention and treatment
Yujing Huang, Xiaohan Guo, Yi Wu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 109
Yujing Huang, Xiaohan Guo, Yi Wu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 109
An optimized messenger RNA vaccine candidate protects non-human primates from Zika virus infection
Brooke Bollman, Naveen Nunna, Kapil Bahl, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 33
Brooke Bollman, Naveen Nunna, Kapil Bahl, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 33
Immunogenicity and protection of a variant nanoparticle vaccine that confers broad neutralization against SARS-CoV-2 variants
James Logue, Robert M. Johnson, Nita Patel, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 16
James Logue, Robert M. Johnson, Nita Patel, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 16
Nanoparticle display of prefusion coronavirus spike elicits S1-focused cross-reactive antibody response against diverse coronavirus subgenera
Geoffrey B. Hutchinson, Olubukola M. Abiona, Cynthia T. Ziwawo, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 13
Geoffrey B. Hutchinson, Olubukola M. Abiona, Cynthia T. Ziwawo, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 13
Different configurations of SARS-CoV-2 spike protein delivered by integrase-defective lentiviral vectors induce persistent functional immune responses, characterized by distinct immunogenicity profiles
Martina Borghi, Alessandra Gallinaro, Maria Franca Pirillo, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
Martina Borghi, Alessandra Gallinaro, Maria Franca Pirillo, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
Immunogenicity and efficacy of a novel multi-patch SARS-CoV-2/COVID-19 vaccine candidate
Beatriz Perdiguero, Laura Marcos-Villar, María López‐Bravo, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
Beatriz Perdiguero, Laura Marcos-Villar, María López‐Bravo, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
Mosaic RBD nanoparticles protect against multiple sarbecovirus challenges in animal models
Alexander A. Cohen, Neeltje van Doremalen, Allison J. Greaney, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 8
Alexander A. Cohen, Neeltje van Doremalen, Allison J. Greaney, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 8
Preclinical immunogenicity and protective efficacy of a SARS-CoV-2 RBD-based vaccine produced with the thermophilic filamentous fungal expression system Thermothelomyces heterothallica C1
Mariana González-Hernández, Franziska K. Kaiser, Imke Steffen, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 2
Mariana González-Hernández, Franziska K. Kaiser, Imke Steffen, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 2
Potent neutralization of SARS-CoV-2 variants by RBD nanoparticle and prefusion-stabilized spike immunogens
Marcos C. Miranda, Elizabeth Kepl, Mary Jane Navarro, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access
Marcos C. Miranda, Elizabeth Kepl, Mary Jane Navarro, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access
Comparison of media for a human peripheral blood mononuclear cell-based in vitro vaccine evaluation system
Shuran Gong, Putri Ayu Fajar, Jacqueline de Vries‐Idema, et al.
Clinical and Experimental Vaccine Research (2023) Vol. 12, Iss. 4, pp. 328-328
Open Access | Times Cited: 1
Shuran Gong, Putri Ayu Fajar, Jacqueline de Vries‐Idema, et al.
Clinical and Experimental Vaccine Research (2023) Vol. 12, Iss. 4, pp. 328-328
Open Access | Times Cited: 1
Nanoparticle display of prefusion coronavirus spike elicits S1-focused cross-reactive protection across divergent subgroups
Geoffrey B. Hutchinson, Olubukola M. Abiona, Cynthia T. Ziwawo, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 2
Geoffrey B. Hutchinson, Olubukola M. Abiona, Cynthia T. Ziwawo, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 2
Preclinical immunogenicity and protective efficacy of a SARS-CoV-2 RBD based vaccine produced with the thermophilic filamentous fungal expression system Thermothelomyces heterothallica, C1.
Albert D. M. E. Osterhaus, Mariana González-Hernández, Franziska K. Kaiser, et al.
Research Square (Research Square) (2023)
Open Access
Albert D. M. E. Osterhaus, Mariana González-Hernández, Franziska K. Kaiser, et al.
Research Square (Research Square) (2023)
Open Access
